Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06232525
Other study ID # SEAH-63
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 2, 2024
Est. completion date February 2025

Study information

Verified date January 2024
Source Sanliurfa Education and Research Hospital
Contact Alev Esercan, MD
Phone +905052634609
Email alevesercan@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare the efficacy of transobturator tape (TOT) operation and urethral ligament plication operation in stress incontinence patients. The main question: - Which operation is more effective in treatment of stress incontinence? - Which operation has less complication and risks? Participants will be followed about 5 days, 2.5 months, 6 months and 1 year after the operation and asked about the continence status and complications.


Description:

The study will be a double-blind, prospective experimental study. When examining patients with stress urinary incontinence complaints, POP-Q staging in terms of pelvic organ prolapse before surgery, symptom interrogation in the examination of the anterior/middle and posterior compartments based on the Integral Theory in the pelvic floor examination, Urogenital Distress Inventory (UDI-6) for the evaluation of urinary incontinence and Female sexual function scale (FSFI) scales will be filled in to evaluate sexual functions. One group of patients will undergo transobturator tape (TOT), and the other group will undergo urethral ligament plication surgery. Patients who are decided to have surgery due to stress urinary incontinence will undergo TOT surgery and urethral plication surgery, without being told which surgery they will have (both surgeries will be performed with the mid-urethral approach and the patient will not be told whether mesh is used or not), with a draw system in which the computer program will decide on the surgeon who will perform the surgery. The surgeon will always be the same person (Esercan A), and on the morning of the surgery, he will be told about the surgery he will perform and will be asked not to share it with the patient. At the end of the 5th day, 2.5 months, 6 months and 1 year after the surgery, the patients were called for control and examined by the same doctor, different from the doctors who wrote the surgery and the publication. POP-Q staging was performed again in terms of pelvic organ prolapse, based on the Integral Theory in the pelvic floor examination. During the examination of the anterior/middle and posterior compartments, symptom inquiry, Urogenital Distress Inventory (UDI-6) for the evaluation of urinary incontinence and Female Sexual Function Scale (FSFI) scales will be filled in for the evaluation of sexual functions. The FSFI survey has 19 questions; It evaluates 6 main factors: sexual desire, sexual arousal, lubrication, orgasm, satisfaction and pain/discomfort. The highest total raw score that can be obtained in this scale is 95, the lowest raw score is 4, and after multiplying the coefficients, the highest score is 36 and the lowest score is 2. Impact coefficients used to score the entire scale; It was determined as 0.6 for sexual desire, 0.3 for sexual arousal and lubrication, and 0.4 for orgasm, satisfaction and pain/discomfort. A FSFI score below 26.55 is defined as compatible with sexual dysfunction. Additionally, if there are any complications, they will be recorded in detail.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date February 2025
Est. primary completion date April 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Being 18 years or older 2. Presence of stress urinary incontinence symptoms 3. Agreeing to have surgery Exclusion Criteria: 1. Pregnancy 2. Being under 18 years of age 3. Suspicion of malignancy 4. History of previous mid-urethral sling or urinary incontinence surgery 5. Being diagnosed with intrinsic sphincter (urethral) insufficiency 6. Urinary incontinence due to neurological bladder

Study Design


Intervention

Procedure:
transobturator tape operation (TOT)
TOT surgery: With an 18 French Foley urinary catheter, the sling passes through the skin in the groin, the obturator foramen, the back of the adductor longus tendon, and the midurethral vaginal incision; extends 1 cm below the midpoint of the urethra, the tape is held in place without sutures by its interface with the patient's tissue. After the mesh is placed, the incision in the suburethral midline is closed.
urethral ligament plication
Urethral ligament plication: With an 18 French Foley urinary catheter, a vertical incision of approximately 3 cm is made in the anterior-lateral wall sulcus of the vagina on the right and left lines, 2 cm laterally from the midline, with the urethral meatus remaining in the midline, and external urethral ligaments on both sides inferolateral to the urethra, sutured in the midline by using 2-0 or 3-0 polyester sutures on both sides separately. The incised anterior vaginal tissue is closed one by one with 2-0 rapid Vicryl.

Locations

Country Name City State
Turkey Sanliurfa Education and Research Hospital Sanliurfa

Sponsors (1)

Lead Sponsor Collaborator
Alev Esercan

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subjective finding of no urinary incontinence The patient has no urinary incontinence and a significant decrease in the UDI-6 score. After the first day of the operation day and all of the follow-up (postoperative 5th day, 2.5 th month, 6th month and first year)
Primary Objective finding of no urinary incontinence Tap test negativity (if the patient's bladder is filled with 300cc physiological saline and the patient is made to cough and no urine leakage is observed, it is considered negative) After the first day of the operation day and all of the follow-up(postoperative 5th day, 2.5 th month, 6th month and first year)
Secondary complications the presence of postoperative complications; Any complications such as presence of urinary incontinence, leg pain, inability to urinate, hematuria, pelvic organ injury postoperative 5th day, 2.5 th month, 6th month and first year
See also
  Status Clinical Trial Phase
Completed NCT03625843 - Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing N/A
Not yet recruiting NCT06012370 - Injecting Plasma-rich Platelets & Hyaluronic Acid for Patients With Stress Urinary Incontinence N/A
Completed NCT03672461 - A Group-Based Therapeutic Yoga Intervention for Urinary Incontinence in Ambulatory Older Women N/A
Completed NCT03010800 - A Feasibility Device Study to Prevent Female Urinary Stress Incontinence N/A
Recruiting NCT05768607 - Laparoscopic Extraperitoneal ( Modified) Burch Colposuspension N/A
Recruiting NCT03397368 - Evaluation of Transperineal US in Stress Incontinence
Completed NCT05210738 - Single-incision Sling vs Urethral Bulking During Prolapse Surgery for Occult Stress Incontinence
Terminated NCT03847922 - Nitrous Oxide for Analgesia During Office Urethral Bulking Phase 4
Completed NCT03866356 - The Effectiveness of a Stress Incontinence Care Protocol N/A
Completed NCT03267719 - Intravaginal Laser Treatment of Mild and Moderate Stress Incontinence N/A
Completed NCT03301818 - Vaginal Elasticity Assessment Before and After Surgical Repair for Urinary Stress Incontinence. N/A
Recruiting NCT05858125 - Social Media Navigation Aid Kits for Urinary Incontinence N/A